Af­ter Chi­na Trodelvy OK, Ever­est Med­i­cines CEO re­signs and the hunt is on for his re­place­ment

Shang­hai-based Ever­est Med­i­cines CEO has hit the com­pa­ny’s ex­it door.

Ker­ry Blan­chard has re­signed as the CEO and as a mem­ber of the board of di­rec­tors, ef­fec­tive im­me­di­ate­ly, Ever­est an­nounced Fri­day. Af­ter spend­ing near­ly 17 years at Eli Lil­ly where he rose to the rank of VP, Blan­chard spent three years as a top ex­ec­u­tive for oth­er phar­ma com­pa­nies in Chi­na, in­clud­ing a year-long stint at In­novent Bi­o­log­ics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER